1min read
PREVIOUS ARTICLE Athlete's Foot owner lifts FY ... NEXT ARTICLE Reverse mortgages help, but ri...

Shares in Blackmores have jumped as much as 11 per cent after the vitamin maker reported a 19 per cent lift in full-year profit.

The company, reporting its first full-year results since chief executive Christine Holgate left to take charge of Australia Post, said net profit rose to $70 million on the back of strong demand from Asia and what it called operational efficiencies.

Revenue for the 12 months to June 30 rose 8.9 per cent to a record $601.1 million, boosted by a 22 per cent increase in China and 20 per cent growth in the rest of Asia.

The company, which on Tuesday said it was expanding into weight loss with a $9 million deal to buy the Improny brand from pharmaceuticals firm Probiotec, declared a fully franked final dividend of $1.55 – up 15 cents from a year ago.

Chief executive Richard Henfrey, who replaced Ms Holgate last year, said consumer demand across all regions and businesses remained strong.

“Revenue was a record for the group and in the financial year we sold more product than ever in our 86-year history,” Mr Henfrey said.

“The strongest growth continues to come from our businesses in Asia, which delivered record sales in June.”

Mr Henfrey said June’s signing of a joint business plan with Alibaba should lead to growth in the coming year across the Chinese online retail giant’s platforms.

The results mark a recovery after full-year profit tumbled 41 per cent to $59 million in 2016/17 following declining Chinese sales.

In FY17 Blackmores reported $692.8 million in sales, however this has been reduced to $552.2 million following an accounting change.

In FY18 Blackmores changed its revenue reporting from invoice sales to net sales.

At 1200 AEST, Blackmores shares were up $13.88, or 9.6 per cent, at $159.13.

BLACKMORES GOOD MEDICINE FOR INVESTORS

* Net profit up 19pct to $70m

* Revenue up 8.9pct to $601.1m

* Final dividend up 15 cents to $1.55, fully franked